CHRISTINE OCAMPO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTINE OCAMPO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTINE OCAMPO. CHRISTINE OCAMPO is Vice President, Finance in AVANIR PHARMACEUTICALS, INC. ($AVNR).
Latest Insider Trading Transactions of CHRISTINE OCAMPO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 4.18 | 55,000 | 229,900 | 17,500 | |
| Sep 17 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 9.45 | 55,000 | 519,750 | 79,871 | 134.9 K to 79.9 K (-40.78 %) |
| Aug 28 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 6.10 | 2,110 | 12,871 | 79,871 | 82 K to 79.9 K (-2.57 %) |
| May 16 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 4.88 | 11,900 | 58,072 | 3,000 | 14.9 K to 3 K (-79.87 %) |
| May 16 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 5.13 | 25,596 | 131,307 | 81,981 | 107.6 K to 82 K (-23.79 %) |
| Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 15,050 | 0 | 107,577 | 92.5 K to 107.6 K (+16.27 %) |
| Feb 14 2014 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 29,325 | 0 | 92,527 | 63.2 K to 92.5 K (+46.40 %) |
| Dec 20 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.63 | 2,450 | 6,445 | 63,202 | 65.7 K to 63.2 K (-3.73 %) |
| Dec 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 2.84 | 17,250 | 48,990 | 17,250 | |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 38,700 | 34,056 | 0 | |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 15,000 | 13,200 | 0 | |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 4,000 | 3,520 | 0 | |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.28 | 57,700 | 189,418 | 65,652 | 123.4 K to 65.7 K (-46.78 %) |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 38,700 | 34,056 | 123,352 | 84.7 K to 123.4 K (+45.72 %) |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 15,000 | 13,200 | 84,652 | 69.7 K to 84.7 K (+21.54 %) |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 4,000 | 3,520 | 69,652 | 65.7 K to 69.7 K (+6.09 %) |
| May 17 2013 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.29 | 20,000 | 65,832 | 65,652 | 85.7 K to 65.7 K (-23.35 %) |
| Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 2.59 | 32,500 | 84,175 | 32,500 | |
| Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 8,963 | 0 | 85,652 | 76.7 K to 85.7 K (+11.69 %) |
| Dec 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 21,288 | 0 | 76,689 | 55.4 K to 76.7 K (+38.43 %) |
| Dec 05 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.55 | 2,845 | 7,258 | 55,401 | 58.2 K to 55.4 K (-4.88 %) |
| Sep 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.53 | 65,000 | 34,450 | 65,000 | |
| Sep 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.49 | 65,000 | 226,824 | 58,246 | 123.2 K to 58.2 K (-52.74 %) |
| Sep 19 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.53 | 65,000 | 34,450 | 123,246 | 58.2 K to 123.2 K (+111.60 %) |
| Mar 07 2012 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | P | 2.60 | 3,000 | 7,795 | 3,000 | 0 to 3 K |
| Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 1.85 | 90,000 | 166,500 | 90,000 | |
| Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 13,750 | 0 | 58,246 | 44.5 K to 58.2 K (+30.90 %) |
| Dec 16 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 6,250 | 0 | 44,496 | 38.2 K to 44.5 K (+16.34 %) |
| Dec 06 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.38 | 2,676 | 6,372 | 38,246 | 40.9 K to 38.2 K (-6.54 %) |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 64,500 | 56,760 | 38,700 | |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 12,000 | 10,560 | 15,000 | |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 12,000 | 10,560 | 4,000 | |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 1.20 | 3,750 | 4,500 | 0 | |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.62 | 92,250 | 242,055 | 40,922 | 133.2 K to 40.9 K (-69.27 %) |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 64,500 | 56,760 | 133,172 | 68.7 K to 133.2 K (+93.92 %) |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 12,000 | 10,560 | 68,672 | 56.7 K to 68.7 K (+21.17 %) |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 12,000 | 10,560 | 56,672 | 44.7 K to 56.7 K (+26.86 %) |
| Nov 14 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 1.20 | 3,750 | 4,500 | 44,672 | 40.9 K to 44.7 K (+9.16 %) |
Page: 1